Меню
Страницы
Статья
Information for the donor
Analysis of Key Performance Indicators for the Regional Blood Center (9 Months of 2026)
The blood service of the Kyzylorda Region is represented by a Category IV regional blood center.
Donors and Donations.
During the first nine months of 2026, a total of 9,955 individuals presented themselves to donate blood and blood components (compared to 9,707 in the same period of 2025), representing an increase of 248 people (2.5%) year-on-year.
Of these, 1,773 individuals (17.8%) were deferred at the pre-donation stage (compared to 1,848 individuals, or 19%, in the same period of 2025).
The number of donors during the first nine months of 2026 totaled 6,096, an increase of 1.8% compared to the previous year (5,978 donors in the same period of 2025).
First-time donors accounted for 2,072—or 34%—of the total donor pool during the reporting period (compared to 2,117—or 35.4%—in the same period of 2025).
The total number of blood and blood component donations during the first nine months of 2026 rose by 3.9% (an increase of 323 donations), reaching 8,182 (compared to 7,859 in the same period of 2025). Regarding the composition of donations: compared to the previous period, the share of whole blood donations increased by 2% to 81.6% (6,676 donations); the share of plasma donations increased by 58.3% to 0.3% (24 donations); the share of cellular component donations increased by 12% to 18.1% (1,482 donations); and automated plasmapheresis accounted for 100% of all plasmapheresis procedures.
The indicators for "proportion of unpaid donations," "proportion of paid donations," and "number of mobile/outreach donations" during the reporting period were 99.7%, 0.3%, and 6.5%, respectively; for the first nine months of 2025, these figures were 99.7%, 0.3%, and 5.5%.
In the overall donation breakdown, voluntary donations accounted for 74.8% during the first nine months of 2026 (compared to 78.4% in the same period of 2025), while directed (family/relative) donations accounted for 25.2% (compared to 21.6% in the same period of 2024).
The average number of donations per 1,000 population was 9.7 for the first nine months of 2026, compared to 9.3 for the same period in 2025.
Collection of blood and blood components.
Blood collection at the regional blood center is carried out both at the facility and via mobile/outreach teams.
During the reporting period, 7,065.3 liters of preserved blood were collected, representing a 5.4% increase compared to the previous year (6,682.8 liters in the first nine months of 2025). Ensuring immunological and infectious safety.
To enhance the immunological and infectious safety of blood products, additional processing methods are employed: plasma quarantine, pathogen inactivation in plasma and platelet concentrates, and leukofiltration of blood and its components.
The proportion of leukofiltered red blood cells during the reporting period remained at the same level as the first nine months of 2025, standing at 100%.
The proportion of leukofiltered platelets was 100% (compared to 100% in the first nine months of 2025). Additionally, the proportion of platelets that underwent both pathogen inactivation and leukofiltration was 100% (compared to 100% in the first nine months of 2025).
The proportion of plasma that underwent pathogen inactivation was 17.7% (compared to 4.2% in the first nine months of 2025), while the proportion of quarantined plasma was 82.3% (compared to 95.8% in the first nine months of 2025).
Screening for markers of transfusion-transmissible infections.
During the first nine months of 2026, the utilization rate of the two-stage diagnostic method for markers of transfusion-transmissible infections (combining immunological detection of antibodies and antigens of infectious agents with molecular-genetic detection of viral RNA/DNA) was 100% (compared to 100% in the first nine months of 2025).
The proportion of screening performed using ELISA/CLIA methods on automated closed-system analyzers during the reporting period was 100% (compared to 100% in the first nine months of 2025). At the regional blood center, ELISA (and CLIA) diagnostic testing fully complies with current regulatory requirements and is performed using automated, closed-system analyzers.
During the reporting period, the proportion of donations resulting in blood or blood components deemed unsuitable for transfusion or processing into medicinal products was 4.7% (compared to 5.7% in the first nine months of 2025).
Supply of safe blood components to medical organizations.
The volume of red blood cell-containing components supplied to medical organizations (MOs) during the first nine months of 2026 totaled 5,734 units (5,777 doses in the first nine months of 2025); the supply of fresh frozen plasma (FFP) increased by 4.4% (3,461 doses vs. 3,307 doses in the first nine months of 2025), and the supply of platelets increased by 15.6% (2,987 doses vs. 2,520 doses in the first nine months of 2025).
During the first nine months of 2026, the proportion of blood components supplied to MOs that had undergone additional processing to ensure infectious and immunological safety averaged as follows across the blood center:
- 100% FFP (quarantined and virus-inactivated) (100% in the first nine months of 2025), comprising 82.3% leukoreduced and quarantined FFP (95.8% in the first nine months of 2025) and 17.7% virus-inactivated FFP (4.2% in the first nine months of 2025);
- 100% leukoreduced red blood cells (100% in the first nine months of 2025); - 100% of platelets are leukoreduced and virus-inactivated (100% by September 2025).
Analysis of the regional blood center's key performance indicators for the first half of 2026
The Kyzylorda region's blood service is represented by a category IV regional blood center.
Donors and donations.
In the first half of 2026, a total of 6,908 people donated blood and its components, representing a 4.7% increase compared to the first half of 2025 (6,540 people in 2025). Of these, 19.1% (1,266 people) were donated before donation, and 19.1% (1,252 people) in the first half of 2025.
In the first half of 2026, the number of donors who made donations was 4,664, which is 170 donors more than in the first half of 2025 (4,494).
The share of first-time donors during the reporting period was 31.6% (1,473), compared to 32.2% (1,447) in the first half of 2025.
The total number of blood and blood component donations in the first half of 2026 was 5,642, which is 6.2% more (2025 - 5,288) than in the first half of 2025. Compared to the first half of 2025, the number of blood donations decreased by 14.1%, while cell donations increased by 3.9%.
The donation structure was distributed as follows: blood donations accounted for 79.9% (84% in the first half of 2025), cell donations accounted for 19.9% (16% in the first half of 2025), and plasma donations accounted for 0.2% (0% in the first half of 2025).
The share of unpaid donations in the first half of 2026 was 99.9% (100% in the first half of 2025), while paid donations accounted for 0.1% (0% in the first half of 2025).
Voluntary donations accounted for 75.7% of all donations in the first half of 2026 (86.2% in the first half of 2025), while family donations accounted for 24.3% (13.8% in the first half of 2025).
The average donation rate per thousand people in the first half of 2026 was 6.7, compared to 6.2 in the first half of 2025.
Blood and blood component collection.
Blood collection at the regional blood center is carried out both inpatient and mobile.
During the reporting period, 4,958.5 liters of preserved blood were collected, an 11.3% increase compared to the previous year (4,403.1 liters in 2025). To fulfill requests from medical organizations, 13 blood drives were conducted, during which 447 donors donated blood, accounting for 7.9% of the total number of donations. In the first half of 2025, seven more drives were conducted, during which 225 donors donated blood.
Screening for transmissible infection markers.
In the first half of 2026, the use of the two-stage method for diagnosing transmissible infection markers (a combination of an immunological method for detecting antibodies and antigens of infectious agents and a molecular genetic method for detecting viral RNA/DNA) was 100% (100% in the first half of 2025).
The share of screening using the ELISA/HLA method on automatic closed-type analyzers during the reporting period was 100% (100% in the first half of 2025). The share of donations from which the collected blood and its components were deemed unsuitable for transfusion and processing into products during the reporting period was 4.8% (5.7% in 2025).
Provision of blood products to healthcare organizations.
The number of red blood cell-containing components issued to healthcare organizations in the first half of 2026 decreased by 4.1% (3,789 doses compared to 3,952 doses in the first half of 2025), all types of fresh frozen plasma decreased by 19.2% (2,050 doses compared to 2,029 doses in the first half of 2025), and the platelet count increased by 24.2% (2,151 doses compared to 1,630 doses in the first half of 2025).
Ensuring the immunological and infectious safety of blood products. To improve the immunological and infectious safety of blood products, additional processing methods such as plasma quarantine, pathogen inactivation in plasma and platelet concentrate, and leukofiltration of blood and its components are used.
The share of leukofiltered red blood cells issued to healthcare organizations in the first half of 2026 was 100% (100% in the first half of 2025).
The share of platelets that underwent pathogen virus inactivation and leukofiltration was 100% (100% in the first half of 2025).
The share of plasma that underwent quarantine and leukofiltration was 86.7% (97.1% in the first half of 2025), and 13.3% underwent virus inactivation (2.9% in the first half of 2025).
Analysis of the main performance indicators of the regional blood center for the 9 months of 2025
The Kyzylorda Region Blood Service is represented by a Category IV Regional Blood Center.
Donors and Donations.
In the first nine months of 2025, 9,707 people applied to donate blood and its components (in the first nine months of 2024: 10,076 people), a decrease of 369 people (3.7%) compared to the previous year.
Of these, 1,848 people were referred to the pre-donation stage, representing 19.0% of the total (in the first nine months of 2024: 1,897 people, representing 18.8%).
In the first nine months of 2025, the number of donors was 5,978, an increase of 2.0% compared to the previous year (in the first nine months of 2024: 5,859 donors).
The share of first-time donors in the total number of donors during the reporting period was 2,117 (35.4%) (2024:9 months – 2,165 (36.9%)).
The total number of blood and blood component donations for the first 9 months of 2025 decreased by 3.9% (an increase of 320 donations) and amounted to 7,859 (2024:9 months – 8,179).
In the structure of donations: compared to the previous period, the share of blood donations decreased by 3.8% and amounted to 83.2% (6,545 donations), the share of plasma donations decreased by 44.4% and amounted to 0.2% (10 donations), the share of cell donations decreased by 4.1% and amounted to 16.6% (1,304 donations), the share of hardware plasmapheresis of the total number of plasmapheresis procedures was 100%.
The indicators "share of voluntary donations," "share of paid donations," and "number of on-site donations" for the reporting period were 99.9%, 0.1%, and 5.5%, respectively. For the first nine months of 2024, these figures were 99.8%, 0.2%, and 6.0%.
Of all donations, the share of voluntary donations for the first nine months of 2025 was 78.4% (2024: 77.9%), while the share of family donations was 21.6% (2024: 22.1%).
The average number of donations per thousand people for the first nine months of 2025 was 9.3, and for the first nine months of 2024, 9.7.
Blood and blood component procurement. Blood collection at the regional blood center is carried out both inpatient and on-site.
During the reporting period, 6,682.8 liters of preserved blood were collected, a 5.7% decrease compared to the previous year (2024: 7,086.9 liters).
Ensuring immunological and infection safety.
To enhance the immunological and infection safety of blood products, additional processing methods are used, including plasma quarantine, pathogen inactivation in plasma and platelet concentrate, and leukofiltration of blood and its components.
The average percentage of leukofiltered red blood cells during the reporting period corresponds to the level for the first nine months of 2024 and is 100%.
The percentage of leukofiltered platelets was 100%. (2024: 100%). The proportion of platelets that underwent pathogen virus inactivation and leukofiltration was 100% (9 months of 2024 - 100%).
The proportion of plasma that underwent virus inactivation during the first 9 months of 2025 was 0.5% (9 months of 2024 - 5.6%).
Screening for transmissible infection markers.
During the first 9 months of 2025, the use of a two-stage method for diagnosing transmissible infection markers (a combination of an immunological method for detecting antibodies and antigens of infectious agents and a molecular genetic method for detecting viral RNA/DNA) was 100% (9 months of 2024 - 100%).
The proportion of screening using the ELISA/ILA method on automatic closed-type analyzers during the reporting period was 100% (9 months of 2024 - 100%). At the regional blood center, ELISA (ELISA) diagnostics are fully compliant with current regulatory requirements and are performed using automated, closed-loop systems.
The share of donations from which the collected blood and its components were deemed unsuitable for transfusion and processing into products during the reporting period was 5.7% (9 months of 2024 – 6.5%).
Providing healthcare organizations with safe blood components.
The number of erythrocyte-containing components issued to healthcare organizations (hereinafter referred to as MOs) decreased by 6.0% in the first 9 months of 2025 (5,777 doses versus 6,147 doses in the first 9 months of 2024), fresh frozen plasma decreased by 14.0% (3,307 doses versus 3,846 doses in the first 9 months of 2024), and platelets decreased by 6.7% (2,520 doses versus 2,701 doses in the first 9 months of 2024). Over the first 9 months of 2025, the average proportion of blood components issued to medical organizations that underwent additional processing to ensure infection and immunological safety at the blood center was:
- 100% of quarantined and virus-inactivated FFP (100% in the first 9 months of 2024), including 95.8% of leukofiltered, quarantined FFP (91.9% in the first 9 months of 2024) and 4.2% of virus-inactivated FFP (8.1% in the first 9 months of 2024);
- 100% of leukofiltered red blood cells (100% in the first 9 months of 2024);
- 100% of leukofiltered, virus-inactivated platelets (100% in the first 9 months of 2024).
Analysis of the main performance indicators of the regional blood center for the 6 months of 2025
The blood service of the Kyzylorda region is represented by the regional blood center of category IV.
Donors and donations
In total, 6,540 people applied for blood and its components in the first half of 2025, which is 4.6% less than in the first half of 2024 (2024.1 half - 6,852 people). Of these, 19.1% (1,252 people) were allocated at the pre-donation stage, in the first half of 2024 19.1% (1,309 people).
In the first half of 2025, the number of donors who made donations was 4494, which is 0.8% less (38 donors) than in the first half of 2024 (4532).
The share of primary donors for the reporting period was 32.2% (1447), compared to 32.0% (1451) in the first half of 2024.
The total number of blood and blood component donations in the first half of 2025 was 5288 donations, which is 4.6% less (5543) than in the first half of 2024. Compared to the first half of 2024, the number of blood donations decreased by 1.3%, cell donations decreased by 17.6%. There were no plasma donations in the first half of 2025 (16 donations in the first half of 2024).
In the structure of donations, the shares were distributed as follows: the share of blood donations was 84.0% (81.1% in the first half of 2024), the share of cell donations was 16.0% (18.6% in the first half of 2024), the share of plasma donations was 0.0% (0.3% in the first half of 2024).
The share of gratuitous donations in the first half of 2025 was 100.0%, (99.8% in the first half of 2024), the share of paid donations was 0.0% (0.2% in the first half of 2024).
In the structure of all donations, the share of gratuitous (voluntary) donations for the first half of 2025 was 83.5% (2024.1 half - 76.0%), the share of gratuitous (related) donations was 16.5% (2024.1 half - 24.0%).
The average number of donations per thousand population for the first half of 2025 was 6.2, for the first half of 2024 - 6.6.
Blood and its components procurement
Blood procurement in the regional blood center is carried out in stationary and mobile conditions.
During the reporting period, 4403.1 liters of preserved blood were collected, which is 12.9% less than last year (2024 - 5052.6 liters). To fulfill the requests of medical organizations, 7 visits were carried out, during which 225 donors donated blood, which amounted to 4.3% of the total number of donations. In the first half of 2024, 14 visits were also carried out, during which 372 donors donated blood.
Screening for transmissible infection markers
For the first half of 2025, the indicator of the use of a two-stage method for diagnosing transmissible infection markers (a combination of an immunological method for determining antibodies + antigens of infectious agents and a molecular genetic method for detecting viral RNA / DNA) was 100% ( 2024. First half - 100%).
The share of screening by the ELISA / ICLAA method on automatic closed-type analyzers for the reporting period was 100% ( 2024. First half - 100%).
The share of donations from which the collected blood and its components were recognized as unsuitable for transfusion and processing into drugs for the reporting period was 5.7% (2024 half-year - 6.4%).
Provision of medical organizations with blood products
The number of red blood cell-containing components issued to medical organizations in the first half of 2025 decreased by 4.6% (3952 doses versus 4144 doses in the first half of 2024), all types of fresh frozen plasma decreased by 19.2% (2029 doses versus 2511 doses in the first half of 2024), the number of platelets decreased by 20.5% (1630 doses versus 2050 doses in the first half of 2024).
Ensuring immunological and infectious safety of blood products
To improve the immunological and infectious safety of blood products, additional processing methods are used, such as plasma quarantine, pathogen inactivation in plasma and platelet concentrate, leukofiltration of blood and its components.
The share of leukofiltered erythrocytes issued to medical organizations in the first half of 2025 was 100% (2024, first half - 100%).
The share of platelets that underwent virus inactivation of pathogens and leukofiltration was 100% (2024, first half - 100%).
The share of plasma that underwent quarantine and leukofiltration was 97.1% (2024, first half - 99.5%), and the virus inactivation procedure was 2.9% (2024, first half - 0.5%).
Analysis of the main performance indicators of the regional blood center for the first quarter of 2025
The blood service of the Kyzylorda region is represented by the regional blood center of category IV.
Donors and donations
In total, 3,248 people applied for blood and its components in the first quarter of 2025 (2024 quarter - 3,067 people), which is 181 people (5.6%) more than last year, of which 674 people were allocated at the pre-donation stage, which amounted to 20.8% (2024 quarter - 629 people, which amounted to 20.5%).
For the first quarter of 2024, the number of donors of the regional blood center was 2,511, which is 5.1% more than last year (2024 quarter - 2,382 donors).
The share of primary donors from the total amounted to 739 during the reporting period - 29.4% (2024 Q1 - 631 - 26.4%).
The total number of blood and its component donations for the first quarter of 2025 increased by 5.3% (136 more donations) and amounted to 2574 (2024 Q1 - 2438).
In the structure of donations: compared to the first quarter of 2024, the share of blood donations increased by 8.5% and amounted to 87.2% (2244 donations), the share of cell donations decreased by 13.4% and amounted to 12.8% (330 donations), the share of plasma donations decreased by 3 donations and amounted to 0.0% (0 donations). The share of hardware plasmapheresis from the total number of plasmapheresis procedures is 100%.
The indicators - "the share of gratuitous donations", "the share of paid donations", "the number of donations in mobile settings" for the reporting period amounted to 100.0%, 0.0% and 2.2%, respectively, for the first quarter of 2024 these indicators were 99.96%, 0.04% and 3.1%.
In the structure of all donations, the share of voluntary donations for the first quarter of 2025 amounted to 84.0% (2024.Q. - 83.0%), the share of related donations amounted to 16.0% (2024.Q. - 17.0%).
The average number of donations per thousand population for the first quarter of 2025 was 3.0, for the first quarter of 2024 2.9.
Blood and its components procurement
Blood procurement in the regional blood center is carried out in stationary and mobile conditions.
During the reporting period, 2025.9. of preserved blood was prepared, compared to the previous year it decreased by 2.0% (2024 ІQ - 2068.1 years).
Ensuring immunological and infectious safety.
To improve the immunological and infectious safety of blood products, additional processing methods are used - plasma quarantine, pathogen inactivation in plasma and platelet concentrate, leukofiltration of blood and its components.
The share of leukofiltered erythrocytes on average for the reporting period corresponds to the level for the first quarter of 2024 and is 100%.
The share of leukofiltered platelets was 100%. (2024 ІQ - 100%). The share of platelets that underwent virus inactivation of pathogens and leukofiltration was 100% (Q1 2024 - 100%).
The share of plasma that underwent the virus inactivation procedure in Q1 2025 was 1.9% (Q1 2024 - 0.1%).
Screening of transmissible infection markers
In Q1 2025, the use of a two-stage method for diagnosing transmissible infection markers (a combination of an immunological method for determining antibodies + antigens of infectious agents and a molecular genetic method for detecting viral RNA/DNA) was 100% (Q1 2024 - 100%).
The share of screening by the ELISA/IHLA method on automatic closed-type analyzers for the reporting period was 100% (2024 quarter - 100%).
In the regional blood center, ELISA (IHLA) diagnostics fully comply with the requirements of the current regulatory legislation and are carried out on automatic closed-type systems.
The share of donations from which the collected blood and its components were recognized as unsuitable for transfusion and processing into drugs for the reporting period was 6.9% (2024 quarter - 5.6%).
Providing healthcare organizations with safe blood components
The number of erythrocyte-containing components issued to healthcare organizations (hereinafter referred to as MO) for the first quarter of 2025 remained at the same level (2015 doses versus 2023 doses for the first quarter of 2024), fresh frozen plasma decreased by 5.6% (1116 doses versus 1182 doses for the first quarter of 2024), platelets decreased by 15.2% (656 doses versus 774 doses for the first quarter of 2024).
In the first quarter of 2025, the share of blood components issued to the Ministry of Defense that underwent additional processing to ensure infectious and immunological safety on average per blood center was:
- 100% of quarantined and virus-inactivated FFP (first quarter of 2024 - 100%), including 95.8% of quarantined FFP (first quarter of 2024 - 99.9%) and 4.2% of virus-inactivated FFP (first quarter of 2024 - 0.1%);
- 100% of leukofiltered erythrocytes (first quarter of 2024 - 100%);
- 100% of leukofiltered virus-inactivated platelets (first quarter of 2024 - 100%).
Analysis of the main performance indicators of the regional blood center for 2024
The blood service of the Kyzylorda region is represented by the regional blood center of category IV. In total, 13,245 people applied for blood and its components in 2024, which is similar to the 13,247 people in 2023.
Of these, 2,464 people were deferred at the pre-donation stage, making up 18.6% (compared to 2,548 people or 19.2% in 2023).
In 2024, the number of donors was 6,900, a decrease of 7.9% from last year’s 7,490 donors.
The number of first-time donors was 2,960, accounting for 42.9% of the total during this period (up from 2,874 or 38.4% in 2023).
The total number of blood donations and its components for 2024 increased by 0.8% (82 more donations), reaching 10,781 (compared to 10,699 in 2023).
In the donation structure, the share of blood donations rose by 0.4% to 84.7% with 9,135 donations (up from 9,100 in 2023). The share of plasma donations decreased by 57.1% to 0.2% with 18 donations (down from 42 in 2023). The share of platelet donations increased by 4.4% to 15.1% with 1,628 donations (up from 1,557 in 2023). The share of hardware plasmapheresis was 100% of the total plasmapheresis procedures. The indicators for "proportion of voluntary donations," "proportion of paid donations," and "number of donations in off-site conditions" for the reporting period were 99.9%, 0.1%, and 4.9%, respectively. In 2023, these indicators were 99.6%, 0.4%, and 6.9%. In the overall donation structure, the share of voluntary donations for 2024 was 75.2% (down from 77.0% in 2023), while related donations made up 24.8% (up from 23.0% in 2023). The average number of donations per thousand population for 2024 was 12.7, the same as in 2023.
Blood and its components procurement
Blood procurement in the regional blood center is carried out in stationary and mobile conditions.
During the reporting period, 8971.3 liters of preserved blood were prepared, compared to the previous year at the same level (2023 - 8980.5 liters).
Ensuring immunological and infectious safety
To enhance the safety of blood products against infections, additional processing methods are employed, including plasma quarantine, pathogen inactivation in plasma and platelet concentrate, and leukofiltration of blood and its components. The proportion of leukofiltered erythrocytes for the reporting period is 100%, matching the level for 2023. The share of leukofiltered platelets is also 100% (2023 - 100%). Additionally, 100% of platelets underwent virus inactivation and leukofiltration (2023 - 100%). In 2024, the percentage of plasma that underwent the virus inactivation procedure was 0.5% (2023 - 1.1%). For screening transmissible infection markers, the use of a two-stage method (combining an immunological method for detecting antibodies and antigens of infectious agents with a molecular genetic method for detecting viral RNA/DNA) was 100% in 2024 (2023 - 100%). The share of screening using the ELISA/IHCLA method on automatic closed-type analyzers was also 100% (2023 - 100%). In the regional blood center, ELISA (IHLA) diagnostics fully comply with current regulatory requirements and are conducted on automatic closed-type systems. The percentage of donations from which the collected blood and its components were deemed unsuitable for transfusion and processing into drugs for the reporting period was 6.9% (2023 - 8.2%).
Providing healthcare organizations with safe blood components
The number of erythrocyte-containing components issued to healthcare organizations (hereinafter referred to as MO) in 2024 decreased by 0.5% (8122 doses versus 8166 doses in 2023), fresh frozen plasma decreased by 12.8% (4959 doses versus 5688 doses in 2023), the number of platelets increased by 7.3% (3202 doses versus 2967 doses in 2022).
In 2024, the share of blood components issued to the Ministry of Defense that underwent additional processing to ensure infectious and immunological safety on average in the blood center was:
- 100% of quarantined and virus-inactivated FFP (2023 - 100%), including leukofiltered, quarantined FFP 93.6%, (2023 - 94.4%) and virus-inactivated FFP 6.4% (2023 - 5.6%);
- 100% of leukofiltered red blood cells (2023 - 100%);
- 100% of leukofiltered, virus-inactivated platelets (2023 - 100%).
Analysis of the basic indicators of activities of the regional blood center for 9 months of 2024
The blood service of the Kyzylorda region is represented by the regional blood center of category IV.
Donors and donations.
In total, 10,076 people applied for blood and its components in the first 9 months of 2024 (2023, 9 months - 9,922 people), which is 154 people (1.5%) more than in the previous year.
Of these, 1,897 people were allocated to the pre-donation stage, which was 18.8% (2023, 9 months - 1,854 people, which was 18.9%).
In the first 9 months of 2024, the number of donors was 5,859, which is 2.4% less than in the previous year (2023, 9 months - 6,004 donors).
The share of primary donors from the total amounted to 20164 for the reporting period - 36.9% (2023 9 months - 2086 - 34.7%).
The total number of blood and its components donations for 9 months of 2024 increased by 1.4% (111 more donations) and amounted to 8179 (2023 9 months - 8068).
In the structure of donations: compared to the previous period, the share of blood donations decreased by 1.6% and amounted to 83.2% (6801 donations), the share of plasma donations decreased by 48.6% and amounted to 0.2% (18 donations), the share of cell donations increased by 17.4% and amounted to 16.6% (1360 donations), the share of hardware plasmapheresis from the total number of plasmapheresis procedures was 100%.
The indicators "proportion of gratuitous donations", "proportion of paid donations", "number of donations in off-site conditions" for the reporting period amounted to 99.8%, 0.2% and 6.0%, respectively, for 9 months of 2023 these indicators were 99.3%, 0.4% and 5.3%.
In the structure of all donations, the share of voluntary donations for 9 months of 2024 amounted to 77.9% (2023.9 months - 75.6%), the share of related donations amounted to 22.1% (2023.9 months - 24.4%).
The average number of donations per thousand population for 9 months of 2024 was 9.7, for 9 months of 2023 was 9.6.
Blood and its components preparation.
Blood procurement in the regional blood center is carried out in stationary and mobile conditions.
During the reporting period, 7086.9 liters of preserved blood were collected, an increase of 5.9% compared to the previous year (2023, 9 months - 6669.4 liters).
Ensuring immunological and infectious safety.
To improve the immunological and infectious safety of blood products, additional processing methods are used - plasma quarantine, pathogen inactivation in plasma and platelet concentrate, leukofiltration of blood and its components.
The share of leukofiltered erythrocytes on average for the reporting period corresponds to the level for 9 months of 2023 and is 100%.
The share of leukofiltered platelets was 100%. (2023, 9 months - 100%). The proportion of platelets that underwent virus inactivation of pathogens and leukofiltration was 100% (2023, 9 months - 100%). The proportion of plasma that underwent virus inactivation for 9 months of 2023 was 5.6% (2023, 9 months - 1.2%).
Screening for transmissible infection markers.
For the first 9 months of 2024, the use rate of the two-stage method for diagnosing transmissible infection markers (a combination of the immunological method for detecting antibodies + antigens of infectious agents and the molecular genetic method for detecting viral RNA/DNA) was 100% (2023, 9 months - 100%).
The share of screening by the ELISA/IHLA method on automatic closed-type analyzers for the reporting period was 100% (2023, 9 months - 100%).
In the regional blood center, ELISA (IHLA) diagnostics fully comply with the requirements of the current regulatory legislation and are carried out on automatic closed-type systems.
The share of donations from which the collected blood and its components were recognized as unsuitable for transfusion and processing into drugs for the reporting period was 6.5% (2023, 9 months - 8.5%).
Providing healthcare organizations with safe blood components.
The number of erythrocyte-containing components issued to healthcare organizations (hereinafter referred to as MO) decreased by 2.9% in the first 9 months of 2024 (6,147 doses versus 6,333 doses in the first 9 months of 2023), fresh frozen plasma decreased by 9.3% (3,846 doses versus 4,240 doses in the first 9 months of 2023), and platelets increased by 19.9% (2,701 doses versus 2,163 doses in the first 9 months of 2023).
Over the first 9 months of 2024, the share of blood components issued to the Ministry of Defense that underwent additional processing to ensure infectious and immunological safety, on average at the blood center, was:
- 100% of FFP quarantined and virus-inactivated (9 months of 2023 - 100%), including leukofiltered, quarantined FFP 91.9%, (9 months of 2023 - 95.8%) and virus-inactivated FFP 8.1% (9 months of 2023 - 4.2%);
- 100% of leukofiltered erythrocytes (9 months of 2023 - 100%);
- 100% of leukofiltered, virus-inactivated platelets (9 months of 2023 - 100%).
Analysis of the basic indicators of activities of the regional blood center for 6 months of 2024
Blood service of the Kyzylorda region was presented by the regional blood center of 4th category.
Donors and donation
For the first half of 2024, 6852 people requested for giving blood and its components (in the first half of 2023 – 6610 people). In comparison to the previous year, it increased for 3.5%. 629 people were devoted before the donation, which amounted to 20.5% (650 people in the first quarter of 2023, or 19.8%). Of these, 19.1% (1309 people) were allocated at the pre-donation stage, and 19.7% (1302 people) in the first half of 2023.
In the first half of 2024, the number of donors who made donations was 4532, which is 3.3% more (150 donors) than in the first half of 2023 (4382).
The share of primary donors for the reporting period was 32.0% (1451), versus 24.8% (1318) in the first half of 2023.
Total number of blood donations and blood components for the first half of 2024 amounted to 5543, which is 4.2% more than in the first half of 2023. Compared to the first half of 2023, blood donations have decreased by 2.0%, cell donations have increased by 32.0% and plasma dosages have decreased by 11.1%.
In the structure of donations, the shares were distributed as follows: the share of blood donations was 81.1% (86.5% in the first half of 2023), the share of cell donations was 18.6% (13.2% in the first half of 2023), the share of plasma 0.3% (0.3% in the first half of 2023). At the same time, the share of hardware plasma procurement in the total volume of plasmapheresis procedures was 100%.
The share of gratuitous donations in the first half of 2024 was 99.8% (99.7% in the first half of 2023), the share of paid donations was 0.2% (0.3% in the first half of 2023).
In the structure of all donations, the share of free (voluntary) donations for the first half of 2024 amounted to 76.0% (2023 half year - 80.0%), the share of free (related) donations amounted to 24.0% (2023, 1st half - 20 .0%).
The average number of donations per thousand population for the first half of 2024 was 6.6, for the first half of 2023 6.3.
Preparation of blood and its components
The preparation of blood and its components provided in stationery and field conditions.
A blood bank of 5052 (6 liters) was made for the reported period. The increase in comparison to the previous year was 16.7% (2023 - 4210,0 liters). In order to respond to medical organizations' requests, 14 visits were conducted, during which 372 donors donated blood, representing 6.7% of the total number of donors. 187 donors donated blood during 6 visits conducted in the first half of 2023.
Screening for markers of vector-borne infections
In the first half of 2024, the use of two-stage diagnostic methods for detecting markers of vector-borne infections reached 100% (combination of immunological method for determining antibodies and antigens of infectious agents and molecular-genetic method of viral RNA/DNA detection). In the first half of 2023 – 100%.
The share of IFA screening methods on closed type automatic analyzers, for the reported period amounted to 100%. (in the first half of 2023 – 100%).
The share of donations from which the collected blood and its components were recognized as unsuitable for transfusion and processing into drugs during the reporting period was 6.4% (2023-2023 - 8.6%).
Provision of safe blood components to medical organizations.
The number of erythrocyte-containing components issued to medical organizations in the first half of 2024 decreased by 3.0% (4144 doses versus 4276 doses in the first half of 2023), various types of fresh frozen plasma decreased by 8.8% (2511 doses versus 2753 doses in the first half of 2023). half of 2023), the platelet count increased by 33.3% (2050 doses versus 1,368 doses in the first half of 2023).
Ensuring the immunological and infectious safety of blood products.
To increase the immunological and infectious safety of blood products, additional processing methods are used, such as plasma quarantine, inactivation of pathogens in plasma and platelet concentrate, and leukofiltration of blood and its components.
The share of leukofiltered red blood cells issued to medical organizations in the first half of 2024 was 100% (2023, first half - 100%).
The proportion of platelets that underwent virus inactivation of pathogens and leukofiltration was 100% (1st half of 2023 - 100%).
The share of plasma that underwent quarantine and leukofiltration was 99.5% (in the 1 half of 2023 - 94.1%), and the virus inactivation procedure was 0.5% (in the 1 half of 2023 - 5.9%).
Analysis of the basic indicators of activities of the regional blood center for the first quarter of 2024
Blood service of the Kyzylorda region was presented by the regional blood center of 4th category.
Donors and donation
For the first quarter of 2024, 3067 people requested for giving blood and its components (in the first quarter of 2023 – 3276 people). In comparison to the previous year, it decreased for 209 people (6.4%). 629 people were devoted before the donation, which amounted to 20.5% (650 people in the first quarter of 2023, or 19.8%).
For the first quarter of 2024, the number of donors of the regional blood center amounted to 2382, in comparison to the previous year, it increased to 5.0% (in the first quarter of 2023 – 2509 donors).
Share of primary donors from the total number amounted for the reported period 631 or 26.4% (in the first quarter of 2023 – 603-24.0%).
Total number of blood donations and blood components for the first quarter of 2024 decreased for 7.2% (less than 188 donations), and amounted to 2438 (in the first quarter of 2023 – 2626).
In the donation structure, compared to the first quarter of 2023, the percentage of blood donations decreased to 10.6%, totaling 2054 donations. Plasma donations decreased to 0.1%, with 7 donations. Cell donations increased to 16.3%, totaling 381 donations. The share of hardware plasmapheresis from the total number of plasmapheresis procedures was 100%.
Indicators - “relative proportion of unpaid blood donations”, “relative proportion of paid donations”, “the number of donations in the field conditions” for the reported period amounted to 99.96%, 0.04% and 3.1%., respectively for the first quarter of 2023, these indicators showed 99.7%, 0.3% and 0.0%.
In the structure of all donations, the share of voluntary donations for the first quarter of 2024 was 83.0% (in the first quarter of 2023 - 75.0%), the share of related donations was 17.0% (in the first quarter of 2023 - 25.0%).
The average number of donations per thousand population for the first quarter of 2024 was 2.9. For the first quarter of 2023 - 3.1.
Preparation of blood and its components
The preparation of blood and its components provided in stationery and field conditions.
A blood bank of 2068 was made for the reported period. The increase in comparison to the previous year was 3.1% (in the first quarter of 2023 – 2003, 8 liters).
Ensuring immunological and infectious safety
To ensure the safety of blood products from immunological and infectious risks, additional processing methods like plasma quarantine, pathogen inactivation in plasma, platelet concentration, leukocyte reduction in blood and its components are employed.
The share of leukofiltered red blood cells on average for the reporting period corresponds to the level for the first quarter of 2023 and is 100%.
The proportion of leukofiltered platelets was 100%. (in the first quarter of 2023 - 100%). At the same time, the proportion of platelets that underwent virus inactivation of pathogens and leukofiltration was 100% (in the first quarter of 2023 - 100%).
The share of plasma that underwent the viruinactivation procedure in the first quarter of 2024 was 0.1% (in the first quarter of 2023 – 1.0%).
Screening for markers of vector-borne infections
In the first quarter of 2024, the use of two-stage diagnostic methods for detecting markers of vector-borne infections reached 100% (combination of immunological method for determining antibodies and antigens of infectious agents and molecular-genetic method of viral RNA/DNA detection). In the first quarter of 2023 – 100%.
The share of IFA screening methods on closed type automatic analyzers, for the reported period amounted to 100%. (in the first quarter of 2023 – 100%).
At the IFA Regional Blood Centre (IHLA), diagnostics fully comply with the requirements of the current regulatory legislation and are carried out on automatic closed-type systems.
The proportion of donations from which the harvested blood and its components were found to be unsuitable for transfusion and processing for drugs during the reporting period was 5.6% (2023. I sq. - 10.9%).
Provision of safe blood components to medical organizations
The number of erythros-containing components issued to medical organizations (hereinafter - MO) for the first quarter of 2024 decreased by 9.4% (2023 doses versus 2232 doses for the first quarter of 2023), fresh frozen plasma decreased by 9.4% (1182 doses versus 1305 doses for the first quarter of 2023), platelets increased by 16.3% (774 doses versus 648 doses in the first quarter of 2023).
For the first quarter of 2024, the share of MO blood components that passed additional processing to ensure infectious and immunological safety on average for the blood center was:
- 100% quarantined and virus-inactivated FFP (in the first quarter of 2023 - 100%), including quarantined FFP 100.0% (in the first quarter of 2023 - 97.9%) and virus-inactivated FFP 0.0% (in the first quarter of 2023 - 2.1%);
- 100% leuko-filtered red blood cells (in the first quarter of 2023 – 100%);
- 100% leuko-filtered virus-inactivated platelets (in the first quarter of 2023 - 100%).
Analysis of the main performance indicators of the regional blood center for 9 months of 2023
The blood service of Kyzylorda region is represented by the regional blood center of category IV.
Donors and donations
In just 9 months of 2023, 9,922 people applied to donate blood and its components (9,215 people in 2022), which increased by 707 people (7.1%) compared to last year.
Of these, 1854 people were allocated at the pre-donation stage, which was 18.9% (2022, 9 months - 2138 people, which was 23.2%).
For 9 months of 2023, the number of donors amounted to 6004, increasing by 12.9% compared to last year (2022 9 months - 5232 donors).
The share of primary donors from the total number during the reporting period was 2086–34.7% (2022 9 months – 1850 – 35.4%).
The total number of donations of blood and its components for 9 months of 2023 increased by 12.2% (991 more donations) and amounted to 8068 (9 months 2022 – 7077).
In the structure of donations: compared to the previous period, the share of blood donations increased by 13.0% and amounted to 85.6% (6910 donations), the share of plasma donations increased by 40.0% and amounted to 0.4% (35 donations), the share cell donations increased by 7.3% and amounted to 13.9% (1123 donations), the share of hardware plasmapheresis from the total number of plasmapheresis procedures was 100%.
Indicators - “share of gratuitous donations”, “share of paid donations”, “number of donations on-site” for the reporting period amounted to 99.6%, 0.4% and 5.3%, respectively for 9 months of 2022, these indicators were 99.7%, 0.3% and 3.2%.
In the structure of all donations, the share of voluntary donations for 9 months of 2023 was 75.6% (2022 9 months - 76.0%), the share of related donations was 24.4% (2022 9 months - 24.0%).
The average number of donations per thousand population for 9 months of 2023 was 9.6, for 9 months of 2022 was 8.5.
Preparation of blood and its components
Blood collection at the regional blood center is carried out in stationary and on-site conditions.
During the reporting period, 6669.4 liters of canned blood were collected, which increased by 11.2% compared to last year (2022, 9 months - 5923.1 liters).
Ensuring immunological and infectious safety
To increase the immunological and infectious safety of blood products, additional processing methods are used - quarantine of plasma, inactivation of pathogens in plasma and platelet concentrate, leukofiltration of blood and its components.
The share of leukofiltered red blood cells on average for the reporting period corresponds to the level for 9 months of 2022 and is 100%.
The proportion of leukofiltered platelets was 100%. (2022, 9 months - 100%). At the same time, the proportion of platelets that underwent virus inactivation of pathogens and leukofiltration was 100% (2022, 9 months - 100%).
The share of plasma that underwent the virus inactivation procedure for 9 months of 2023 was 1.2% (2022, 9 months - 0.9%).
Screening for markers of vector-borne infections
For 9 months of 2023, the rate of use of a two-stage method for diagnosing markers of vector-borne infections (a combination of an immunological method for determining antibodies + antigens of infectious agents and a molecular genetic method for detecting viral RNA/DNA) was 100% (2022 9 months - 100%).
The share of screening using ELISA/CLLA on automatic closed-type analyzers during the reporting period was 100% (2022 9 months - 100%).
At the regional blood ELISA center (EIA), diagnostics fully comply with the requirements of current regulatory legislation and are carried out using closed-type automatic systems.
The share of donations from which the collected blood and its components were recognized as unsuitable for transfusion and processing into drugs during the reporting period was 8.5% (2022, 9 months - 1.5%).
Providing medical organizations with safe blood components
The number of erythros-containing components issued to medical organizations (hereinafter - MO) for 9 months of 2023 increased by 6.9% (6333 doses versus 5899 doses for 9 months of 2022), fresh frozen plasma increased by 6.8% (4240 doses versus 3950 doses for 9 months of 2022), platelets increased by 5.5% (2163 doses versus 2044 doses for 9 months of 2022).
For 9 months of 2023, the share of blood components issued to the Moscow Region that underwent additional processing to ensure infectious and immunological safety on average for the blood center was:
- 100% quarantined and virus-inactivated FFP (9 months 2022 - 100%), including leukofiltered FFP, quarantined 95.8% (9 months 2022 - 94.6%). and virus-inactivated FFP 4.2% (9 months of 2022 - 5.4%);
- 100% leukofiltered red blood cells (9 months 2022 – 100%);
- 100% leukofiltered virus-inactivated platelets (9 months of 2022 - 100%).
Analysis of the main performance indicators of the regional blood center for the first half of 2023
The blood service of Kyzylorda region is represented by the regional blood center of category IV.
Donors and donations
In total, in the first half of 2023, 6,610 people applied to donate blood and its components, which is 5.8% more compared to the first half of 2022 (H2022 - 6,229 people). Of these, 19.7% (1302 people) were allocated at the stage before donation, in the first half of 2022 23.2% (1446 people).
In the first half of 2023, the number of donors who donated was 4382, which is 7.7% more (338 donors) than in the first half of 2022 (4044).
The share of primary donors for the reporting period was 30.0% (1318), against 32.5% (1314) in the first half of 2022.
The total number of donations of blood and its components in the first half of 2023 amounted to 5308 donations, which is 9.9% more (4783) than in the first half of 2022. Compared to the first half of 2022, the number of blood donations increased by 10.6%, cell donation increased by 4.3%, and plasma donation increased by 38.9%.
In the structure of donations, the shares were distributed as follows: the share of blood donations was 86.5% (85.7% in the 1st half of 2022), the share of cell donations was 13.2% (14.0% in the 1st half of 2022), the share of plasma donations was 0.3% (0.2% in the 1st half of 2022). At the same time, the share of hardware plasma preparation in the total volume of plasmapheresis procedures was 100%.
The share of gratuitous donations in the first half of 2023 amounted to 99.7% (99.8% in the first half of 2022), the share of paid donations was 0.3% (0.2% in the first half of 2022).
In the structure of all donations, the share of gratuitous (voluntary) donations for the 1st half of 2023 amounted to 77.2% (2022 1st half - 75.0%), the share of gratuitous (related) donations amounted to 22.5% (2022 1st half - 25.0%).
The average number of donations per thousand population for the first half of 2023 was 6.3, for the first half of 2022 it was 5.8.
Preparation of blood and its components
Blood collection in the regional blood center is carried out in stationary and on-site conditions.
During the reporting period, 4222.4 liters were prepared. of canned blood, which is 6.7% more than last year (2022 - 3938.1l.). To fulfill the requests of medical organizations, 6 visits were carried out, at which 187 donors donated blood, which accounted for 3.5% of the total number of donations. In the first half of 2022, 8 visits were also carried out, during which 194 donors donated blood.
Screening for markers of vector-borne infections
For the first half of 2023, the rate of using the two-stage method for diagnosing markers of transmissible infections (a combination of the immunological method for detecting antibodies + antigens of infectious agents and the molecular genetic method for detecting viral RNA/DNA) was 100% (2022, first half - 100% ).
The share of screening by ELISA / ICL method on closed-type automatic analyzers for the reporting period amounted to 100% (2022 Іpol. - 100% ).
The share of donations from which the donated blood and its components were deemed unsuitable for transfusion and processing into drugs for the reporting period amounted to 8.6% (2022H1 - 1.8%).
Providing medical organizations with blood products
The number of erythrocyte-containing components issued to medical organizations in the first half of 2023 increased by 4.6% (4176 doses against 3983 doses in the first half of 2022), various types of fresh frozen plasma increased by 2.3% (2753 doses against 2691 doses in the first half of 2022), platelets increased by 4.1% (1368 doses against 1312 doses for the first half of 2022).
Ensuring the immunological and infectious safety of blood products
To improve the immunological and infectious safety of blood products, additional processing methods are used, such as plasma quarantine, inactivation of pathogens in plasma and platelet concentrate, leukofiltration of blood and its components.
The share of leukofiltered erythrocytes issued to medical organizations for the first half of 2023 amounted to 100% (2022, first half - 100%).
The proportion of platelets that underwent virus inactivation of pathogens and leukofiltration was 100% (2022, 1st half - 100% ).
The proportion of plasma that underwent quarantine and leukofiltration was 94.1% (2022, first half - 94.6%), and the virus inactivation procedure was 5.9% (2022, half - 5.4%).
Analysis of the main performance indicators of the regional blood center for 2021
The blood service of the Kyzylorda region is represented by the regional blood center of the IV category.
Donors and donations.
In total, 11317 people applied for blood donation and its components in 2021 (by 2020 – 10978 people), which increased by 339 people (3.0%) compared to last year.
Of these, 2,425 people were allocated at the pre-donation stage, which was 21.4% (2020 - 2,514 people, which was 22.9%).
In 2021, the number of donors amounted to 6,151, increased by 7.2% compared to last year (by 2020 - 5,706 donors).
The share of primary donors from the total number for the reporting period was 2406 - 39.4% (2020 - 2043 - 35.8%).
The total number of donations of blood and its components in 2021 increased by 4.8% ( 428 more donations ) and it amounted to 8892 (2020 - 8464).
In the structure of donations: compared to the previous period, the share of blood donations increased by 2.4% and amounted to 85.8% (7633 donations) (2020 - 7447), the share of plasma donations decreased by 66.7% and amounted to 0.6% (18 donations) (2020 - 54), the share of platelet donations increased by 22.4% and amounted to 11.4% (1241 donations) (2020 - 963), the share of hardware plasmapheresis from the total number of procedures plasmapheresis was 100%.
The indicators - "the share of gratuitous donations", "the share of paid donations", "the number of donations in field conditions" for the reporting period amounted to 99.9%, 0.1% and 14.2%, respectively, for 2020, these indicators were 99.5%, 0.5% and 16.5%.
In the structure of all donations, the share of voluntary donations in 2021 was 80.0% (2020 - 75.0%), the share of related donations was 20.0% (2020 - 25.0%).
The average number of donations per thousand population for 2021 was 10.7., for 2020 10.4.
Preparation of blood and its components.
Blood procurement in the regional blood center is carried out in stationary and on-site conditions.
During the reporting period, 7264.4 liters of canned blood were harvested, which increased by 9.3% compared to last year (by 2020 - 6585.5 liters).
Ensuring immunological and infectious safety.
To increase the immunological and infectious safety of blood products, additional treatment methods are used - plasma quarantine, inactivation of pathogens in plasma and platelet concentrate, leukofiltration of blood and its components.
The proportion of leukofiltered erythrocytes on average for the reporting period corresponds to the level for 2020 and is 100%.
The proportion of leukofiltered platelets was 100%. (2020 - 100%). At the same time, the proportion of platelets that underwent viral activation of pathogens and leukofiltration was 100% (2020 - 100%).
The proportion of plasma that underwent the virus activation procedure in 2021 was 0.9% (2020 - 1.9%).
Screening of markers of vector-borne infections.
In 2021, the indicator of the use of a two-stage method for diagnosing markers of vector-borne infections (a combination of an immunological method for determining antibodies + antigens of infectious agents and a molecular genetic method for detecting viral RNA/ DNA) was 100% (2020 - 100%).
The share of screening by the ELISA/IHL method on automatic closed-type analyzers for the reporting period was 100% (2020 - 100%).
In the regional blood center of the IFA (IHLA), diagnostics fully complies with the requirements of the current regulatory legislation and is carried out on automatic closed-type systems.
The share of donations from which the harvested blood and its components were found unsuitable for transfusion and processing into drugs for the reporting period was 2.0% (2020 - 2.8%).
Providing medical organizations with safe blood components.
The number of erythro-containing components issued to medical organizations (hereinafter referred to as MO) increased by 2.7% in 2021 (7254 doses versus 7059 doses in 2020), freshly frozen plasma increased by 16.6% (5218 doses versus 4353 doses in 2020), the number of platelets increased by 21.1% (2454 doses versus 1935 doses in 2020).
In 2021, the share of blood components issued to the Ministry of Defense, which underwent additional treatment to ensure infectious and immunological safety, on average, in the blood center was:
- 100% quarantined and virusinactivated (2020 - 100%), including leucofiltered, quarantined 96.0%, (2020- 88.8%) and virusinactivated 4.0% (2020- 11.2%);
- 100% of leukofiltered erythrocytes (2020 - 100%);
- 100% of leukofiltered virusinactivated platelets (2020- 100%).
Analysis of the main performance indicators of the regional blood center for 9 months of 2021
The blood service of Kyzylorda region is represented by the regional blood center of the IV category.
Donors and donations
In just 9 months of 2021, 8493 people applied to give blood and its components (2020 9 months - 8059 people), which is 434 people (5.1%) more than last year.
Of these, at the stage before donation, 1827 people were assigned, which amounted to 21.5% (2020 9 months - 1928 people, which amounted to 23.9%).
For 9 months of 2021, the number of donors amounted to 5071, compared to last year increased by 8.4% (2020 - 9 months - 4664 donors).
The share of primary donors in the total number was 1843–36.3% for the reporting period (2020 - 9 months - 1454–31.3%).
The total number of donations of blood and its components for 9 months of 2021 increased by 8.0% (535 donations more) and amounted to 6666 (2020 - 9 months - 6131).
In the structure of donations: compared to the previous period, the share of blood donations increased by 5.3% and amounted to 85.3% (5685 donations), the share of plasma donations decreased by 64.6% and amounted to 0.3% (17 donations), the share cell donations increased by 27.1% and amounted to 14.5% (964 donations), the share of hardware plasmapheresis from the total number of plasmapheresis procedures was 100%.
Indicators - "the proportion of gratuitous donations", "the proportion of paid donations", "the number of donations in the field" for the reporting period amounted to 99.8%, 0.2% and 15.0%, respectively for 9 months of 2020 these indicators accounted for 99.4%, 0.6% and 16.4%.
In the structure of all donations, the share of voluntary donations for 9 months of 2021 was 75.0% (2020 9 months - 77.0%), the share of related donations was 25.0% (2020 9 months - 23.0%).
The average indicator of the number of donations per thousand population for 9 months of 2021 was 8.1, for 9 months of 2020 7.6.
Collection of blood and its components
The collection of blood in the regional blood center is carried out in stationary and field conditions.
During the reporting period, 5558.5 of canned blood was procured, compared to last year it increased by 14.1% (2020 9 months - 4772.2 liters).
Ensuring immunological and infectious safety
To increase the immunological and infectious safety of blood products, additional processing methods are used - plasma quarantine, inactivation of pathogens in plasma and platelet concentrate, leukofiltration of blood and its components.
The share of leukofiltered erythrocytes on average for the reporting period corresponds to the level for 9 months of 2020 and is 100%.
The proportion of leukofiltered platelets was 100% (2020 - 9 months - 100%). At the same time, the proportion of platelets that underwent virus-inactivation of pathogens and leukofiltration was 100% (2020 - 9 months - 100%).
The share of plasma that underwent the virus inactivation procedure in 9 months of 2021 was 0.7% (in 2020, 9 months - 2.5%).
Screening for markers of transmissible infections
For 9 months of 2021, the indicator of using a two-stage method for diagnosing markers of transmissible infections (a combination of an immunological method for determining antibodies + antigens of infectious agents and a molecular genetic method for detecting viral RNA / DNA) was 100% (2020 - 9 months - 100%).
The proportion of screening by ELISA / ICLA on automatic closed-type analyzers for the reporting period was 100% (2020 - 9 months - 100%).
In the regional blood center, ELISA (IHLA) diagnostics fully comply with the requirements of the current regulatory legislation and is carried out on automatic closed-type systems.
The share of donations from which the harvested blood and its components were found unsuitable for transfusion and processing for drugs in the reporting period amounted to 2.1% (2020 - 9 months - 3.1%).
Providing medical organizations with safe blood components
The number of erythrocontaining components issued to medical organizations (hereinafter - MO) for 9 months of 2021 increased by 6.3% (5337 doses versus 5000 doses for 9 months of 2020), fresh frozen plasma increased by 21.9% (3729 doses versus 2912 doses for 9 months of 2020), platelets increased by 27.2% (1938 doses versus 1409 doses for 9 months of 2020).
For 9 months of 2021, the share of blood components issued by the Ministry of Defense that underwent additional processing to ensure infectious and immunological safety, on average in the blood center, was:
- 100% FFP quarantined and virus-inactivated (9 months 2020 - 100%), including FFP leukofiltered, quarantined 97.9% (9 months 2020 - 83.0%). and FFP virus-inactivated 2.1% (9 months 2020 - 17.0%);
- 100% leukofiltered erythrocytes (9 months 2020 - 100%);
- 100% of leukofiltered viral inactivated platelets (9 months 2020 - 100%).
Analysis of the main indicators of the activity of the regional blood center for 2019
The blood service of Kyzylorda region is represented by a regional blood center of category IV.
Donors and donations.
In total, in 2019, 1,0805 people (2018–9986 people) applied for blood and its components, which increased by 819 people (7.6%) compared to the previous year.
Of these, 3264 people were assigned at the pre-donation stage, which amounted to 30.2% (in 2018, 2492 people, which amounted to 26.0%).
In 2019, the number of donors amounted to 4063, compared with the previous year, decreased by 20.0% (2018 - 5078 donors).
The share of primary donors of the total amount for the reporting period amounted to 1295 - 31.9% (2018 - 2080 - 41.0%).
The total number of donations of blood and its components for 2019 increased by 1.9% (147 more donations) and amounted to 7541 (2018 - 7394).
In the structure of donations: in comparison with the previous period, the share of blood donations increased by 0.6% and amounted to 90.3% (6813 donations), the share of plasma donations decreased by 62.5% and amounted to 0.6% (45 donations), the share donation of cells increased by 25.9% and amounted to 9.0% (683 donations), the proportion of apparatus plasmapheresis of the total number of plasmapheresis procedures was 100%.
The indicators - “specific gravity of donated donations”, “specific gravity of paid donations”, “number of donations in on-site conditions” for the reporting period amounted to 99.9%, 0.1% and 0.2%, respectively, for 2018, these indicators were 99 , 9%, 0.1% and 17.3%.
In the structure of all donations, the share of voluntary donations for 2019 amounted to 80.0% (2018– 79.0%), the share of related donations amounted to 20.0% (2018 - 21.0%).
The average indicator of the number of donations per thousand population for 2019 was 9.4., For 2018 9.3.
Preparation of blood and its components.
Blood procurement in the regional blood center is carried out in stationary and on-site conditions.
During the reporting period, 5595.9 liters of canned blood were procured, compared to the previous year it increased by 9.3% (2018 - 5073.6 liters).
Ensuring immunological and infectious safety.
To increase the immunological and infectious safety of blood products, additional processing methods are used - plasma quarantine, inactivation of pathogens in plasma and platelet concentrate, leukofiltration of blood and its components.
The proportion of leukofiltered red blood cells on average for the reporting period corresponds to the level for 2018 and is 100%.
The proportion of leukofiltered platelets was 100%. (2018 - 100%). At the same time, the percentage of platelets that underwent virus inactivation of pathogens and leukofiltration was 100% (2018 - 100%).
The fraction of plasma that underwent the virus inactivation procedure for 2019 was 4.1% (2018 - 4.2%).
Screening for markers of vector-borne infections.
In 2019, the indicator of using the two-stage method for the diagnosis of transmissible infection markers (a combination of the immunological method for determining antibodies + antigens of infectious agents and the molecular genetic method for detecting viral RNA / DNA) was 100% (2018 - 100%).
The percentage of screening by ELISA / IHLA on closed-type automated analyzers for the reporting period amounted to 100% (100% in 2018).
In the regional ELISA blood center (IHLA), the diagnosis fully complies with the requirements of the current regulatory legislation and is carried out on closed-type automatic systems.
The share of donations, from which the prepared blood and its components were deemed unsuitable for transfusion and processing for drugs, amounted to 0.8% for the reporting period (2018 - 1.7%).
Providing medical organizations with safe blood components.
The number of erythrocontaining components issued to medical organizations (hereinafter - MO) in 2019 increased by 2.9% (6616 doses versus 6424 doses in 2018), freshly frozen plasma decreased by 16.8% (4605 doses versus 5537 doses in 2018. ), platelet count increased by 28.9% (1375 doses versus 978 doses in 2018).
In 2019, the proportion of blood components issued to the Moscow Region that underwent additional processing to ensure infectious and immunological safety in the center of the blood was on average:
- 100% SZP quarantined and virus-inactivated (2018 - 100%), including SZP leukofiltered, quarantined 89.0%, (2018 - 87.9%). and SZP of virus-inactivated 11.0% (2018 - 12.1%);
- 100% leukofiltered red blood cells (2018 - 100%);
- 100% platelets of leukofiltered virus-inactivated (2018 - 100%).